Structural Heart Disease

Structural heart diseases include any issues preventing normal cardiovascular function due to damage or alteration to the anatomical components of the heart. This is caused by aging, advanced atherosclerosis, calcification, tissue degeneration, congenital heart defects and heart failure. The most commonly treated areas are the heart valves, in particular the mitral and aortic valves. These can be replaced through open heart surgery or using cath lab-based transcatheter valves or repairs to eliminate regurgitation due to faulty valve leaflets. This includes transcatheter aortic valve replacement (TAVR). Other common procedures include left atrial appendage (LAA) occlusion and closing congenital holes in the heart, such as PFO and ASD. A growing area includes transcatheter mitral repair or replacement and transcatheter tricuspid valve repair and replacement.

RSS icon
Thumbnail

Skip the clopidogrel? TAVR patients benefit from antiplatelet therapy that includes aspirin only

The risk of major bleeding or life-threatening bleeding events was higher when clopidogrel was included in the patient's treatment strategy. 

Thumbnail

Transcatheter repair for tricuspid regurgitation is safe and effective

Transcatheter tricuspid valve repair consistently led to improved outcomes for patients with tricuspid regurgitation.

Boston Scientific to retire Lotus Edge TAVR program after voluntary recall

The company will now focus its attention on the marketing and development of other solutions.

Thumbnail

TAVR stands tall as ‘the dominant form of aortic valve replacement,’ specialty groups declare

Specialists from the American College of Cardiology and Society of Thoracic Surgeons explored data from more than 276,000 patients who have undergone a TAVR procedure in the last nine years. 

Thumbnail

Wait times for TAVR, SAVR patients are getting longer and longer

The study’s authors tracked data from more than 22,000 patients with severe aortic stenosis.

Thumbnail

Among TAVR patients with AFib, DOACs lead to better survival rates than vitamin K antagonists

However, the two treatment options were associated with similar rates of long-term bleeding and ischemic events. 

Thumbnail

Training for cardiothoracic surgeons may be falling short in one key area

“The association between surgeon experience and operative outcomes has been the subject of debate," the researchers explained.

Thumbnail

New meta-analysis compares early TAVR outcomes for Sapien 3, Evolut valves—and spots some key differences

The new study focused on the early outcomes of more than 24,000 patients who participated in a total of nine different studies.

Displaying 841 - 848 of 1063
Design by Adaptive Theme